secwatch.observer — SEC 8-K summary
======================================

Issuer:     NeuBase Therapeutics, Inc. (—)
CIK:        0001173281
Form:       8-K
Filed at:   2023-09-18T23:59:59+00:00
Accession:  0001104659-23-101595
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NeuBase Therapeutics lowers stockholder meeting quorum to one-third of shares
-----------------------------------------------------------------------------

- Board approved bylaw amendment effective September 15, 2023.
- Quorum changed to one-third of shares outstanding and entitled to vote.
- Amendment intended to improve ability to hold stockholder meetings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173281/000110465923101595/0001104659-23-101595-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173281/000110465923101595/tm2326323d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-101595

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer